Macquarie Group LTD Seagen Inc. Transaction History

Macquarie Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $243,792 - $275,171	1,273 Added 1.5%	86,138 $18.3 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $152 Million - $167 Million	-811,443 Reduced 90.53%	84,865 $16.3 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $7.6 Million - $12.1 Million	-59,567 Reduced 6.23%	896,308 $181 Million
Q4 2022 Feb 21, 2023	BUY	$117.37 - $139.17 $3.21 Million - $3.8 Million	27,315 Added 2.94%	955,875 $123 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $5.51 Million - $7.33 Million	-40,699 Reduced 4.2%	928,560 $127 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $17.6 Million - $29.1 Million	-162,127 Reduced 14.33%	969,259 $172 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $997,308 - $1.32 Million	-8,338 Reduced 0.73%	1,131,386 $163 Million
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $990,718 - $1.33 Million	6,949 Added 0.61%	1,139,724 $176 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $7.59 Million - $9.05 Million	53,272 Added 4.93%	1,132,775 $192 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $135 Million - $161 Million	997,191 Added 1211.48%	1,079,503 $170 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $2.06 Million - $2.85 Million	-14,960 Reduced 15.38%	82,312 $11.4 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $16 Million - $20.6 Million	97,272 New	97,272 $17 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.